Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
35.97
-0.01 (-0.04%)
Jul 22, 2024, 10:22 AM EDT - Market open

BHVN Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Cash & Equivalents
182.71248.4240.0976.0682.51
Short-Term Investments
100.71133.42260.4600
Cash & Cash Equivalents
283.42381.82500.5576.0682.51
Cash Growth
-36.96%-23.72%558.13%-7.82%-
Other Current Assets
65.3360.6386.4218.777.25
Total Current Assets
348.74442.45586.9794.8289.76
Property, Plant & Equipment
16.6917.1917.5113.017.58
Long-Term Investments
00001.18
Goodwill and Intangibles
19.7919.7919.7919.790
Other Long-Term Assets
33.3133.7937.5114.4412.99
Total Long-Term Assets
69.7970.7774.8247.2421.74
Total Assets
418.53513.21661.78142.06111.5
Accounts Payable
36.3915.5845.924.782.76
Other Current Liabilities
50.239.8544.1137.1627.12
Total Current Liabilities
86.5955.4290.0241.9429.88
Long-Term Debt
27.0927.5730.582.80
Other Long-Term Liabilities
3.412.252.412.644.84
Total Long-Term Liabilities
30.529.8132.995.444.84
Total Liabilities
117.0985.24123.0147.3734.72
Total Debt
27.0927.5730.582.80
Debt Growth
-8.99%-9.85%993.35%--
Retained Earnings
-678.8-499.29-91.120-
Comprehensive Income
-0.11-0.070.2800
Shareholders' Equity
301.45427.98538.7734.6916.78
Net Cash / Debt
256.33354.25469.9773.2682.51
Net Cash / Debt Growth
-38.94%-24.62%541.51%-11.21%-
Net Cash Per Share
3.144.9810.501.862.10
Working Capital
262.16387.02496.9552.8959.88
Book Value Per Share
3.696.0112.040.880.43
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).